Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13
Latest In: synthetic cannabinoids
Synthetic cannabinoid maker Nalu Bio raises $12 million
Nalu Bio, a producer of synthetic cannabinoids, said it raised $12 million in a Series A funding round…
News February 28
Utah to seek curbs on delta-8 THC, other synthetics in medical marijuana market
Utah regulators say they’re pushing for new rules governing the presence of delta-8 THC and other synthetic cannabinoids…
News November 29
Sponsored
The Medical Card Has a New Argument
Federal rescheduling handed the medical tier a tax tool it never expected. Whether operators use it — and how fast — is what the next few years of market data…
June 2
Featured
1
Latest Sponsored
